KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

A new preclinical study shows that mRNA delivered through lipid nanoparticles can trigger local antibody production in muscle ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...

메신저 리보핵산(mRNA)의 부작용을 억제해 뇌졸중과 암 질환의 면역치료에 적용할 수 있는 가능성이 제시됐다. KAIST는 화학과 전용웅 교수 연구팀이 mRNA가 단백질을 만드는 시작점과 속도를 조절할 수 있는 ...

Researchers found that using mental models—visual, verbal, or animated—helps people understand mRNA vaccination science, counter misconceptions, and reduce misinformation spread.